Halozyme Therapeutics Inc (HALO)

[biotechinvestor1]

I wonder if you will move the goal post again. When we were in low 30’s you predicted we will be in 20’s for a long time. Then you said we are range bound in the 30’s. Then your “range” move to $40-45 with an upper limit of 45.5

I rather go with fundamentals than gut feelings. With 2024 PE in the low teens and a sustained CAGR of around 30% through 2028, halozyme is still a bargain even if Helen failed to deliver on new deals in 2023. I shared this thesis on this board when we were in the 30’s and it has proven correct. Helen still has not produced new deals or any hype and yet we are about 50% higher. This is due to fundamentals. If you want to call 50% gain, “range bound,” go ahead. I’ll keep enjoying my gains!